Establishment and Validation of a Machine-Learning Prediction Nomogram Based on Lymphocyte Subtyping for Intra-Abdominal Candidiasis in Septic Patients
Jiahui Zhang, Wei Cheng, Dongkai Li, Guoyu Zhao, Xianli Lei, Na Cui
{"title":"Establishment and Validation of a Machine-Learning Prediction Nomogram Based on Lymphocyte Subtyping for Intra-Abdominal Candidiasis in Septic Patients","authors":"Jiahui Zhang, Wei Cheng, Dongkai Li, Guoyu Zhao, Xianli Lei, Na Cui","doi":"10.1111/cts.70140","DOIUrl":null,"url":null,"abstract":"<p>This study aimed to develop and validate a nomogram based on lymphocyte subtyping and clinical factors for the early and rapid prediction of Intra-abdominal candidiasis (IAC) in septic patients. A prospective cohort study of 633 consecutive patients diagnosed with sepsis and intra-abdominal infection (IAI) was performed. We assessed the clinical characteristics and lymphocyte subsets at the onset of IAI. A machine-learning random forest model was used to select important variables, and multivariate logistic regression was used to analyze the factors influencing IAC. A nomogram model was constructed, and the discrimination, calibration, and clinical effectiveness of the model were verified. High-dose corticosteroids receipt, the CD4<sup>+</sup>T/CD8<sup>+</sup> T ratio, total parenteral nutrition, gastrointestinal perforation, (1,3)-β-D-glucan (BDG) positivity and broad-spectrum antibiotics receipt were independent predictors of IAC. Using the above parameters to establish a nomogram, the area under the curve (AUC) values of the nomogram in the derivation and validation cohorts were 0.822 (95% CI 0.777–0.868) and 0.808 (95% CI 0.739–0.876), respectively. The AUC in the derivation cohort was greater than the Candida score [0.822 (95% CI 0.777–0.868) vs. 0.521 (95% CI 0.478–0.563), <i>p</i> < 0.001]. The calibration curve showed good predictive values and observed values of the nomogram; the Decision Curve Analysis (DCA) results showed that the nomogram had high clinical value. In conclusion, we established a nomogram based on the CD4<sup>+</sup>/CD8<sup>+</sup> T-cell ratio and clinical risk factors that can help clinical physicians quickly rule out IAC or identify patients at greater risk for IAC at the onset of infection.</p>","PeriodicalId":50610,"journal":{"name":"Cts-Clinical and Translational Science","volume":"18 1","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11747989/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cts-Clinical and Translational Science","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cts.70140","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
This study aimed to develop and validate a nomogram based on lymphocyte subtyping and clinical factors for the early and rapid prediction of Intra-abdominal candidiasis (IAC) in septic patients. A prospective cohort study of 633 consecutive patients diagnosed with sepsis and intra-abdominal infection (IAI) was performed. We assessed the clinical characteristics and lymphocyte subsets at the onset of IAI. A machine-learning random forest model was used to select important variables, and multivariate logistic regression was used to analyze the factors influencing IAC. A nomogram model was constructed, and the discrimination, calibration, and clinical effectiveness of the model were verified. High-dose corticosteroids receipt, the CD4+T/CD8+ T ratio, total parenteral nutrition, gastrointestinal perforation, (1,3)-β-D-glucan (BDG) positivity and broad-spectrum antibiotics receipt were independent predictors of IAC. Using the above parameters to establish a nomogram, the area under the curve (AUC) values of the nomogram in the derivation and validation cohorts were 0.822 (95% CI 0.777–0.868) and 0.808 (95% CI 0.739–0.876), respectively. The AUC in the derivation cohort was greater than the Candida score [0.822 (95% CI 0.777–0.868) vs. 0.521 (95% CI 0.478–0.563), p < 0.001]. The calibration curve showed good predictive values and observed values of the nomogram; the Decision Curve Analysis (DCA) results showed that the nomogram had high clinical value. In conclusion, we established a nomogram based on the CD4+/CD8+ T-cell ratio and clinical risk factors that can help clinical physicians quickly rule out IAC or identify patients at greater risk for IAC at the onset of infection.
本研究旨在建立并验证一种基于淋巴细胞亚型和临床因素的nomogram腹腔内念珠菌病(IAC)的早期快速预测方法。对633例连续诊断为败血症和腹腔感染(IAI)的患者进行了一项前瞻性队列研究。我们评估了IAI发病时的临床特征和淋巴细胞亚群。采用机器学习随机森林模型选择重要变量,采用多元逻辑回归分析影响IAC的因素。建立了模态图模型,并对模型的判别、校正和临床有效性进行了验证。大剂量皮质类固醇、CD4+T/CD8+ T比值、总肠外营养、胃肠道穿孔、(1,3)-β- d-葡聚糖(BDG)阳性和广谱抗生素使用是IAC的独立预测因素。利用上述参数建立nomogram,推导队列和验证队列nomogram的曲线下面积(AUC)分别为0.822 (95% CI 0.777 ~ 0.868)和0.808 (95% CI 0.739 ~ 0.876)。衍生队列的AUC大于念珠菌评分[0.822 (95% CI 0.777-0.868) vs. 0.521 (95% CI 0.478-0.563)], p +/CD8+ t细胞比值和临床危险因素可以帮助临床医生快速排除IAC或识别在感染开始时IAC风险较大的患者。
期刊介绍:
Clinical and Translational Science (CTS), an official journal of the American Society for Clinical Pharmacology and Therapeutics, highlights original translational medicine research that helps bridge laboratory discoveries with the diagnosis and treatment of human disease. Translational medicine is a multi-faceted discipline with a focus on translational therapeutics. In a broad sense, translational medicine bridges across the discovery, development, regulation, and utilization spectrum. Research may appear as Full Articles, Brief Reports, Commentaries, Phase Forwards (clinical trials), Reviews, or Tutorials. CTS also includes invited didactic content that covers the connections between clinical pharmacology and translational medicine. Best-in-class methodologies and best practices are also welcomed as Tutorials. These additional features provide context for research articles and facilitate understanding for a wide array of individuals interested in clinical and translational science. CTS welcomes high quality, scientifically sound, original manuscripts focused on clinical pharmacology and translational science, including animal, in vitro, in silico, and clinical studies supporting the breadth of drug discovery, development, regulation and clinical use of both traditional drugs and innovative modalities.